Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Interest Expenses of -$380000.0 in Q1 2026, down 61.02% quarter-over-quarter from -$236000.0 in Q4 2025, and up 60.46% on a YoY basis from -$236822.3 in Q1 2025.
Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Interest Expenses history runs 10 years deep, the most recent figure standing at -$380000.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 60.46% year-over-year to -$380000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 2563.77% YoY), while the FY2025 annual figure was -$2.3 million, down 247.73% from the prior year.
- Interest Expenses was -$380000.0 for Q1 2026 at Organogenesis Holdings, down from -$236000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $737000.0 in Q1 2022 to a low of -$961000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $181235.3 across 5 years, with a median of $471000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses jumped 1773.33% in 2023, then tumbled 286.96% in 2025.
- A 5-year view of Interest Expenses shows it stood at -$30000.0 in 2022, then surged by 1773.33% to $502000.0 in 2023, then tumbled by 112.15% to -$61000.0 in 2024, then sank by 286.89% to -$236000.0 in 2025, then plunged by 61.02% to -$380000.0 in 2026.
- The last three Interest Expenses figures came in at -$380000.0 (Q1 2026), -$236000.0 (Q4 2025), and -$415000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | -380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -380,000.00 |
| Mar 31, 2026 | -380,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Sep 30, 2025 | -415,000.00 |
| Sep 30, 2025 | -415,000.00 |
| Jun 30, 2025 | -669,000.00 |
| Jun 30, 2025 | -669,000.00 |
| Mar 31, 2025 | -961,000.00 |
| Mar 31, 2025 | -961,000.00 |
| Dec 31, 2024 | -61,000.00 |
| Dec 31, 2024 | -61,000.00 |
| Sep 30, 2024 | 471,000.00 |
| Sep 30, 2024 | 471,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Mar 31, 2024 | 514,000.00 |
| Mar 31, 2024 | 514,000.00 |
| Dec 31, 2023 | 502,000.00 |
| Dec 31, 2023 | 502,000.00 |